CASE 2. Tamoxifen and uterine abnormalities

C Buijs*, PHB Willemse, DJ Tinga, H Hollema, EG de Vries, MJE Mourits

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    1 Citation (Scopus)
    Original languageEnglish
    Pages (from-to)2505-2507
    Number of pages3
    JournalJournal of Clinical Oncology
    Volume22
    Issue number12
    DOIs
    Publication statusPublished - 15-Jun-2004

    Keywords

    • BREAST-CANCER
    • ENDOMETRIAL CANCER
    • RISK

    Cite this